郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better.

期刊:Pharmaceutical research发表年份:2021作者:Huimin Li; Jiaxing Di; Baowei Peng; Yuhong Xu; Ning Zhang

药效评价Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1.

期刊:Cellular and molecular neurobiology发表年份:2021作者:Ankita Narayan; Amanda Hunkele; Jin Xu; Daniel L Bassoni; Gavril W Pasternak; Ying-Xian Pan

药效评价Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking.

期刊:Molecules (Basel, Switzerland)发表年份:2021作者:Maria Dumitrascuta; Marcel Bermudez; Olga Trovato; Jolien De Neve; Steven Ballet; Gerhard Wolber; Mariana Spetea

药效评价Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5.

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2021作者:Julie V Selkirk; Kevin C Dines; Yingzhuo Grace Yan; Nathan Ching; Deepak Dalvie; Shameek Biswas; Andrea Bortolato; Jeffrey M Schkeryantz; Carlos Lopez; Iliana Ruiz; Richard Hargreaves